| Identification | |
|---|---|
| Name | Cefmenoxime |
| Accession Number | DB00267 (APRD00851) |
| Type | small molecule |
| Description | Cefmenoxime is a third-generation cephalosporin antibiotic. [Wikipedia] |
| Structure |
|
| Categories (*) | |
| Molecular Weight | 511.558 |
| Groups | approved |
| Monoisotopic Weight | 511.051476769 |
| Pharmacology | |
| Indication | Used to treat female gynecologic and obstetric infections caused by susceptible aerobic (including the gonococcus) and anaerobic bacteria. |
| Mechanism of action | The bactericidal activity of cefmenoxime results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cefmenoxime is stable in the presence of a variety of b-lactamases, including penicillinases and some cephalosporinases. |
| Absorption | Bioavailability is approximately 100% following intramuscular injection. |
| Protein binding | 50-70% |
| Biotransformation | Not appreciably metabolized. |
| Route of elimination | Not Available |
| Toxicity | Information on cefmenoxime overdosage in humans is not available. However, with other b-lactam antibiotics, adverse effects following overdosage have included nausea, vomiting, epigastric distress, diarrhea, and convulsions. |
| Affected organisms |
|
| Interactions | |
| Drug Interactions | Not Available |
| Food Interactions | Not Available |
| Penicillin-binding proteins 1A/1B | |
|---|---|
| Name | Penicillin-binding proteins 1A/1B |
| Gene Name | pbpA |
| Pharmacological action | yes |
| Actions | inhibitor |
| References |
|
| DTHybrid score | 0.7833 |
| Peptidoglycan synthetase ftsI | |
| Name | Peptidoglycan synthetase ftsI |
| Gene Name | ftsI |
| Pharmacological action | yes |
| Actions | inhibitor |
| References |
|
| DTHybrid score | 0.019 |